Susquehanna International Group
PPH icon

Susquehanna International Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Susquehanna International Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.75M Buy
84,211
+77,754
+1,204% +$8.28M ﹤0.01% 3316
2025
Q4 		$666K Sell
6,457
-27,485
-81% -$2.67M ﹤0.01% 8143
2025
Q3 		$3.07M Sell
33,942
-19,722
-37% -$1.73M ﹤0.01% 4940
2025
Q2 		$4.72M Buy
53,664
+27,553
+106% +$2.39M ﹤0.01% 4074
2025
Q1 		$2.38M Sell
26,111
-17,964
-41% -$1.62M ﹤0.01% 5152
2024
Q4 		$3.8M Buy
44,075
+15,604
+55% +$1.41M ﹤0.01% 4039
2024
Q3 		$2.71M Sell
28,471
-25,402
-47% -$2.41M ﹤0.01% 4734
2024
Q2 		$4.93M Buy
53,873
+8,183
+18% +$731K ﹤0.01% 3471
2024
Q1 		$4.14M Buy
45,690
+40,870
+848% +$3.58M ﹤0.01% 3950
2023
Q4 		$392K Buy
+4,820
New +$378K ﹤0.01% 9237
2023
Q3 		– Sell
-30,004
Closed -$2.42M – 12751
2023
Q2 		$2.36M Sell
30,004
-5,612
-16% -$439K ﹤0.01% 4816
2023
Q1 		$2.76M Buy
35,616
+18,924
+113% +$1.46M ﹤0.01% 4477
2022
Q4 		$1.3M Buy
16,692
+648
+4% +$47.8K ﹤0.01% 5610
2022
Q3 		$1.08M Sell
16,044
-3,606
-18% -$266K ﹤0.01% 6450
2022
Q2 		$1.51M Buy
19,650
+10,770
+121% +$841K ﹤0.01% 5519
2022
Q1 		$708K Buy
+8,880
New +$680K ﹤0.01% 8052
2021
Q4 		– Sell
-68,848
Closed -$5.12M – 13730
2021
Q3 		$5.01M Buy
68,848
+44,811
+186% +$3.34M ﹤0.01% 3960
2021
Q2 		$1.76M Buy
24,037
+2,765
+13% +$197K ﹤0.01% 6223
2021
Q1 		$1.47M Sell
21,272
-11,959
-36% -$824K ﹤0.01% 6693
2020
Q4 		$2.21M Sell
33,231
-5,304
-14% -$340K ﹤0.01% 4882
2020
Q3 		$2.4M Buy
38,535
+29,376
+321% +$1.86M ﹤0.01% 4273
2020
Q2 		$570K Buy
+9,159
New +$554K ﹤0.01% 7099
2019
Q4 		– Sell
-18,133
Closed -$1.09M – 10420
2019
Q3 		$1.03M Buy
18,133
+13,093
+260% +$750K ﹤0.01% 5620
2019
Q2 		$296K Sell
5,040
-20,377
-80% -$1.18M ﹤0.01% 8347
2019
Q1 		$1.54M Buy
+25,417
New +$1.5M ﹤0.01% 4187
2018
Q4 		– Sell
-21,708
Closed -$1.31M – 9755
2018
Q3 		$1.4M Buy
21,708
+2,036
+10% +$127K ﹤0.01% 4612
2018
Q2 		$1.16M Buy
19,672
+6,307
+47% +$366K ﹤0.01% 5022
2018
Q1 		$758K Sell
13,365
-5,505
-29% -$329K ﹤0.01% 5796
2017
Q4 		$1.12M Buy
18,870
+13,236
+235% +$759K ﹤0.01% 4997
2017
Q3 		$325K Buy
+5,634
New +$320K ﹤0.01% 7252
2017
Q2 		– Sell
-6,073
Closed -$344K – 9682
2017
Q1 		$335K Sell
6,073
-145
-2% -$7.87K ﹤0.01% 7168
2016
Q4 		$327K Buy
6,218
+2,226
+56% +$119K ﹤0.01% 7813
2016
Q3 		$229K Sell
3,992
-38,027
-90% -$2.28M ﹤0.01% 7368
2016
Q2 		$2.46M Buy
42,019
+31,308
+292% +$1.82M ﹤0.01% 3228
2016
Q1 		$616K Buy
+10,711
New +$634K ﹤0.01% 6031
2015
Q4 		– Sell
-19,758
Closed -$1.28M – 9844
2015
Q3 		$1.24M Buy
+19,758
New +$1.39M ﹤0.01% 5235
2015
Q1 		– Sell
-42,197
Closed -$2.71M – 9821
2014
Q4 		$2.71M Buy
42,197
+36,494
+640% +$2.32M ﹤0.01% 3905
2014
Q3 		$363K Sell
5,703
-33,814
-86% -$2.09M ﹤0.01% 7739
2014
Q2 		$2.45M Buy
+39,517
New +$2.35M ﹤0.01% 4260
2013
Q4 		– Sell
-18,793
Closed -$899K – 9236
2013
Q3 		$899K Buy
+18,793
New +$891K ﹤0.01% 5460

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Susquehanna International Group's PPH Position: Q1 2026 in Review

Susquehanna International Group increased its VanEck Pharmaceutical ETF (PPH) stake by 1,204% in Q1 2026, buying an estimated $8.28M and bringing the position to 84,211 shares worth $8.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Susquehanna International Group first reported a position in PPH in Q3 2013 and has held it in 40 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Susquehanna International Group held 84,211 shares of VanEck Pharmaceutical ETF worth $8.75M as of Q1 2026.
  • Susquehanna International Group bought 77,754 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $8.28M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3316 holding.
  • Susquehanna International Group first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and has held it in 40 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.